Aerie Pharma (AERI) Misses Q1 EPS by 7c

Aerie Pharma (NASDAQ: AERI) reported Q1 EPS of ($0.84), $0.07 worse than the analyst estimate of ($0.77). Revenue for the quarter came in at $20.34 million versus the consensus estimate of $20.06 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Capitol Federal Financial names William Skrobacz Jr. as president
• Alcoa closes $2.6B debt offering to fund South32 asset acquisition